10-K Filing

InnovAge Holding Corp. CIK: 1834376 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001558370-21-012679`
Period End Date	20210630
Filing Date	20210923
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	tmb-20210630x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 46 Cash Flow Statement 77 Stockholders Equity 21

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Allowance for loss	`AllowanceForDoubtfulAccountsReceivable`	$4.35M	USD	Point-in-time
Allowance for loss	`AllowanceForDoubtfulAccountsReceivable`	$6.38M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.00M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$112.90M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$201.47M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	135.52M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$2.23M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	132.72M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$1.66M	USD	Point-in-time
Accounts receivable, net of allowance ($4,350 - June 30, 2021 and $6,384 - June 30, 2020)	`AccountsReceivableNetCurrent`	$46.31M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	0.00	shares	Point-in-time
Accounts receivable, net of allowance ($4,350 - June 30, 2021 and $6,384 - June 30, 2020)	`AccountsReceivableNetCurrent`	$32.58M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	102,030.00	shares	Point-in-time
Treasury stock cost per share (in dollars per share)	`TreasuryStockAcquiredAverageCostPerShare`	$4.82	USD	Point-in-time
Treasury stock cost per share (in dollars per share)	`TreasuryStockAcquiredAverageCostPerShare`	$1.89	USD	Annual
Prepaid expenses	`PrepaidExpenseCurrent`	$4.31M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.25M	USD	Point-in-time
Treasury stock cost per share (in dollars per share)	`TreasuryStockAcquiredAverageCostPerShare`	-	USD	Annual
Income tax receivable	`IncomeTaxesReceivable`	$5.40M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$1.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$250.93M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$166.93M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$102.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$142.72M	USD	Point-in-time
Investments	`LongTermInvestments`	$2.65M	USD	Point-in-time
Investments	`LongTermInvestments`	$2.65M	USD	Point-in-time
Deposits and other	`DepositsAndOtherAssetsNoncurrent`	$3.00M	USD	Point-in-time
Deposits and other	`DepositsAndOtherAssetsNoncurrent`	$3.88M	USD	Point-in-time
Equity method investments	`EquityMethodInvestment`	$848.00K	USD	Point-in-time
Equity method investments	`EquityMethodInvestment`	$13.24M	USD	Point-in-time
Goodwill	`Goodwill`	$124.22M	USD	Point-in-time
Goodwill	`Goodwill`	$117.27M	USD	Point-in-time
Goodwill	`Goodwill`	$116.14M	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$5.18M	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$6.52M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$280.82M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$242.70M	USD	Point-in-time
Total assets	`Assets`	$409.63M	USD	Point-in-time
Total assets	`Assets`	$531.75M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$28.88M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$32.36M	USD	Point-in-time
Reported and estimated claims	`ReportedAndEstimatedClaimsCurrent`	$30.29M	USD	Point-in-time
Reported and estimated claims	`ReportedAndEstimatedClaimsCurrent`	$33.23M	USD	Point-in-time
Due to Medicaid and Medicare	`DueToStateAndFederalHealthPrograms`	$7.10M	USD	Point-in-time
Due to Medicaid and Medicare	`DueToStateAndFederalHealthPrograms`	$12.24M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.79M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.94M	USD	Point-in-time
Current portion of capital lease obligations	`FinanceLeaseLiabilityCurrent`	$1.50M	USD	Point-in-time
Current portion of capital lease obligations	`FinanceLeaseLiabilityCurrent`	$2.08M	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$1.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$78.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$76.63M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$15.70M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$9.28M	USD	Point-in-time
Capital lease obligations	`FinanceLeaseLiabilityNoncurrent`	$5.19M	USD	Point-in-time
Capital lease obligations	`FinanceLeaseLiabilityNoncurrent`	$4.09M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.45M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$2.76M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$71.57M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$210.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$301.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$173.79M	USD	Point-in-time
Commitments and Contingencies (See Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 500,000,000 authorized as of June 30, 2021 and 2020; 135,516,513 and 132,718,461 issued shares as of June 30, 2021 and June 30, 2020, respectively	`CommonStockValue`	$136.00K	USD	Point-in-time
Common stock, $0.001 par value; 500,000,000 authorized as of June 30, 2021 and 2020; 135,516,513 and 132,718,461 issued shares as of June 30, 2021 and June 30, 2020, respectively	`CommonStockValue`	$133.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$36.34M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$323.76M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$11.25M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$64.74M	USD	Point-in-time
Less: Treasury stock; 0 and 102,030 shares of common stock at $0.0 and $1.89 per share as of June 30, 2021 and June 30, 2020, respectively	`TreasuryStockValue`	$193.00K	USD	Point-in-time
Total InnovAge Holding Corp.	`StockholdersEquity`	$335.15M	USD	Point-in-time
Total InnovAge Holding Corp.	`StockholdersEquity`	$101.02M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$6.74M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$22.82M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.75M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.44M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$357.96M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$531.75M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$409.63M	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$637.80M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$567.19M	USD	Annual
External provider costs	`ExternalProviderCosts`	$309.32M	USD	Annual
External provider costs	`ExternalProviderCosts`	$272.83M	USD	Annual
Cost of care, excluding depreciation and amortization	`DirectOperatingCosts`	$154.40M	USD	Annual
Cost of care, excluding depreciation and amortization	`DirectOperatingCosts`	$153.06M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$22.24M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$19.00M	USD	Annual
Corporate, general and administrative	`GeneralAndAdministrativeExpense`	$58.48M	USD	Annual
Corporate, general and administrative	`GeneralAndAdministrativeExpense`	$132.33M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.29M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.29M	USD	Annual
Equity loss	`IncomeLossFromEquityMethodInvestments`	$-1.34M	USD	Annual
Equity loss	`IncomeLossFromEquityMethodInvestments`	$-678.00K	USD	Annual
Other operating expense	`OtherOperatingIncomeExpenseNet`	$-920.00K	USD	Annual
Other operating expense	`OtherOperatingIncomeExpenseNet`	$-18.21M	USD	Annual
Total expenses	`CostsAndExpenses`	$516.26M	USD	Annual
Total expenses	`CostsAndExpenses`	$650.14M	USD	Annual
Operating Income (Loss)	`OperatingIncomeLoss`	$-12.34M	USD	Annual
Operating Income (Loss)	`OperatingIncomeLoss`	$50.93M	USD	Annual
Interest expense, net	`InterestExpense`	$14.62M	USD	Annual
Interest expense, net	`InterestExpense`	$16.79M	USD	Annual
Loss on extinguishment of debt	`GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost`	$-14.48M	USD	Annual
Gain on equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$10.87M	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-2.24M	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-681.00K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-15.30M	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-22.63M	USD	Annual
Income (Loss) Before Income Taxes	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	$-34.97M	USD	Annual
Income (Loss) Before Income Taxes	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	$35.63M	USD	Annual
Provision for Income Taxes	`IncomeTaxExpenseBenefit`	$9.87M	USD	Annual
Provision for Income Taxes	`IncomeTaxExpenseBenefit`	$9.77M	USD	Annual
Net Income (Loss)	`ProfitLoss`	$25.77M	USD	Annual
Net Income (Loss)	`ProfitLoss`	$-44.74M	USD	Annual
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-754.00K	USD	Annual
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-513.00K	USD	Annual
Net Income (Loss) Attributable to InnovAge Holding Corp.	`NetIncomeLoss`	$26.28M	USD	Annual
Net Income (Loss) Attributable to InnovAge Holding Corp.	`NetIncomeLoss`	$-43.99M	USD	Annual
Weighted-average number of common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	123.62M	shares	Annual
Weighted-average number of common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	132.62M	shares	Annual
Weighted-average number of common shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	123.62M	shares	Annual
Weighted-average number of common shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	135.23M	shares	Annual
Net income (loss) per share - basic	`EarningsPerShareBasic`	$-0.36	USD	Annual
Net income (loss) per share - basic	`EarningsPerShareBasic`	$0.20	USD	Annual
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$0.19	USD	Annual
Net income (loss) per share - diluted	`EarningsPerShareDiluted`	$-0.36	USD	Annual

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$25.77M	USD	Annual
Net income (loss)	`ProfitLoss`	$-44.74M	USD	Annual
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	$-18.00K	USD	Annual
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	$-1.04M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$8.64M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$6.20M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.29M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.29M	USD	Annual
Gain on equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$10.87M	USD	Annual
Loss on extinguishment of long-term debt	`GainsLossesOnExtinguishmentOfDebt`	$-14.48M	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCostsAndDiscounts`	$550.00K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCostsAndDiscounts`	$1.06M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$543.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.66M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$3.17M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$6.42M	USD	Annual
Loss in equity of nonconsolidated entities	`GainLossInEquityOfNonconsolidatedEntities`	$-678.00K	USD	Annual
Loss in equity of nonconsolidated entities	`GainLossInEquityOfNonconsolidatedEntities`	$-1.34M	USD	Annual
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$2.26M	USD	Annual
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$2.30M	USD	Point-in-time
Change in fair value of contingent consideration	`FairValueOfContingentConsideration`	$920.00K	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.20M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-5.88M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.06M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.99M	USD	Annual
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-1.95M	USD	Annual
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$3.66M	USD	Annual
Deposits and other	`IncreaseDecreaseInDepositOtherAssets`	$874.00K	USD	Annual
Deposits and other	`IncreaseDecreaseInDepositOtherAssets`	$-1.06M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.01M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$6.14M	USD	Annual
Reported and estimated claims	`IncreaseDecreaseInReportedAndEstimatedClaims`	$2.61M	USD	Annual
Reported and estimated claims	`IncreaseDecreaseInReportedAndEstimatedClaims`	$2.04M	USD	Annual
Due to Medicaid and Medicare	`IncreaseDecreaseInDueToStateAndFederalHealthPrograms`	$-8.12M	USD	Annual
Due to Medicaid and Medicare	`IncreaseDecreaseInDueToStateAndFederalHealthPrograms`	$-5.22M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$2.00K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.55M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$43.83M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.84M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.54M	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$169.00K	USD	Annual
Proceeds from net working capital settlements	`ProceedsFromNetWorkingCapitalSettlements`	$1.13M	USD	Annual
Purchase of long term investment	`PaymentsToAcquireLongtermInvestments`	$1.15M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$2.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.54M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.69M	USD	Annual
Distribution to owners	`PaymentsOfDividends`	$9.50M	USD	Annual
Capital contributions	`ProceedsFromContributionsFromParent`	$20.00M	USD	Annual
Payments on capital lease obligations	`FinanceLeasePrincipalPayments`	$1.79M	USD	Annual
Payments on capital lease obligations	`FinanceLeasePrincipalPayments`	$1.83M	USD	Annual
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$25.00M	USD	Annual
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$375.00M	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.93M	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$512.66M	USD	Annual
Payment of financing costs and debt premiums	`PaymentsOfDebtIssuanceCosts`	$14.90M	USD	Annual
Proceeds from initial public offering of common stock	`ProceedsFromIssuanceInitialPublicOffering`	$370.47M	USD	Annual
Treasury stock purchase	`PaymentsForRepurchaseOfCommonStock`	$77.60M	USD	Annual
Payments under acquisition agreements	`PaymentsUnderAcquisitionAgreement`	$3.62M	USD	Annual
Payments related to option cancellation	`PaymentsRelatedToOptionCancellation`	$29.18M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$21.23M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$116.22M	USD	Annual
INCREASE IN CASH, CASH EQUIVALENTS, & RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$89.14M	USD	Annual
INCREASE IN CASH, CASH EQUIVALENTS, & RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$53.37M	USD	Annual
CASH, CASH EQUIVALENTS & RESTRICTED CASH BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.56M	USD	Point-in-time
CASH, CASH EQUIVALENTS & RESTRICTED CASH BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.70M	USD	Point-in-time
CASH, CASH EQUIVALENTS & RESTRICTED CASH BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.20M	USD	Point-in-time
CASH, CASH EQUIVALENTS & RESTRICTED CASH END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.56M	USD	Point-in-time
CASH, CASH EQUIVALENTS & RESTRICTED CASH END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.70M	USD	Point-in-time
CASH, CASH EQUIVALENTS & RESTRICTED CASH END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.20M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$18.03M	USD	Annual
Interest paid	`InterestPaidNet`	$11.55M	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$4.75M	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$7.05M	USD	Annual
Property and equipment included in accounts payable	`PropertyAndEquipmentIncludedInAccountsPayable`	$1.33M	USD	Annual
Property and equipment included in accounts payable	`PropertyAndEquipmentIncludedInAccountsPayable`	$1.35M	USD	Annual
Property and equipment purchased under capital leases	`PropertyAndEquipmentPurchasedUnderCapitalLeases`	$3.49M	USD	Annual
Property and equipment purchased under capital leases	`PropertyAndEquipmentPurchasedUnderCapitalLeases`	$1.40M	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Offering costs	`PaymentsOfStockIssuanceCosts`	$22.60M	USD	Point-in-time
Offering costs	`PaymentsOfStockIssuanceCosts`	$28.45M	USD	Annual
Balances, Beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.75M	USD	Point-in-time
Balances, Beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.44M	USD	Point-in-time
Balances, Beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$357.96M	USD	Point-in-time
Grants of stock options and stock option expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$543.00K	USD	Annual
Treasury stock transaction	`TreasuryStockValueAcquiredCostMethod`	$77.60M	USD	Annual
Treasury stock transaction (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	Annual
Stock Option Cancellation, Value	`StockOptionCancellationValue`	$9.50M	USD	Annual
Time based awards- option cancelation	`AdjustmentsToAdditionalPaidInCapitalTimeBasedAwardsOptionCancelation`	$29.18M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.66M	USD	Annual
Reclassification of warrant liability	`AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability`	$2.26M	USD	Annual
Capital Contributions	`AdjustmentsToAdditionalPaidInCapitalOwnersContribution`	$20.00M	USD	Annual
Initial public offering of common stock, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$370.47M	USD	Annual
Initial public offering of common stock, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.33M	shares	Point-in-time
Consolidation of equity method investment	`NoncontrollingInterestIncreaseFromConsolidationOfEquityMethodInvestment`	$16.84M	USD	Annual
Net income (loss)	`ProfitLoss`	$25.77M	USD	Annual
Net income (loss)	`ProfitLoss`	$-44.74M	USD	Annual
Balances, Ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.75M	USD	Point-in-time
Balances, Ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.44M	USD	Point-in-time
Balances, Ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$357.96M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.